Troubled Drugmaker Teva to Axe over 4,000 Jobs | Ctech
Meet the Investigator – HD Insights
Help 4 HD HIPE Virtual Talks to Dr. Michael Hayden~Prilenia.mp4 on Vimeo
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Sitting down with... Dr Michael Hayden, Prilenia Therapeutics - Drug Discovery World (DDW)
VIP Reception
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Teva In Transition: Generics, Specialty And 'The Space Between' :: Scrip
Incisive Genetics
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva and Microchips : Partnership through Digital Drug Delivery Technology. Opening of Teva R&D Center in Croatia - Israël Science Info
Teva shares surge on corporate shake-up - MarketWatch
At Risk for Huntington's Disease: 'Darkness replaced by hope and light': taking stock of Huntington's disease research
Michael R. Hayden - Wikipedia
ABOUT US | Prilenia Therapeutics
Michael Hayden Net Worth (2023) | wallmine
Teva Pharmaceuticals on Twitter: "Dr. Michael Hayden, head of Teva's global R&D, meets with #HuntingtonsDisease patients and their families at the Vatican. #Hddennomore. https://t.co/LeojD4GEDe" / Twitter
The Difficulties of Cloning a CEO - Bloomberg
Prilenia Therapeutics raises $62.5m, names Michael Hayden CEO - Globes
